Raskin P - Search Results

1

Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial.

Harrison LB, Adams-Huet B, Li X, Raskin P, Lingvay I. Harrison LB, et al. Among authors: raskin p. J Investig Med. 2014 Apr;62(4):676-86. doi: 10.2310/JIM.0000000000000068. J Investig Med. 2014. PMID: 24569485 Free PMC article. Clinical Trial.

2

Anemia associated with new-onset diabetes: improvement with blood glucose control.

Piñero-Piloña A, Litonjua P, Devaraj S, Aviles-Santa L, Raskin P. Piñero-Piloña A, et al. Among authors: raskin p. Endocr Pract. 2002 Jul-Aug;8(4):276-81. doi: 10.4158/EP.8.4.276. Endocr Pract. 2002. PMID: 12173914

3

Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes.

Strowig SM, Avilés-Santa ML, Raskin P. Strowig SM, et al. Among authors: raskin p. Diabetes Care. 2002 Oct;25(10):1691-8. doi: 10.2337/diacare.25.10.1691. Diabetes Care. 2002. PMID: 12351463 Clinical Trial.

4

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR. Raskin P, et al. Diabetes Care. 2003 Sep;26(9):2598-603. doi: 10.2337/diacare.26.9.2598. Diabetes Care. 2003. PMID: 12941725 Clinical Trial.

5

Improved glycemic control without weight gain using triple therapy in type 2 diabetes.

Strowig SM, Avilés-Santa ML, Raskin P. Strowig SM, et al. Among authors: raskin p. Diabetes Care. 2004 Jul;27(7):1577-83. doi: 10.2337/diacare.27.7.1577. Diabetes Care. 2004. PMID: 15220231 Clinical Trial.

6

Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes.

Litonjua P, Piñero-Piloña A, Aviles-Santa L, Raskin P. Litonjua P, et al. Among authors: raskin p. Endocr Pract. 2004 Mar-Apr;10(2):101-6. doi: 10.4158/EP.10.2.101. Endocr Pract. 2004. PMID: 15256325

7

Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences.

Newton CA, Raskin P. Newton CA, et al. Among authors: raskin p. Arch Intern Med. 2004 Sep 27;164(17):1925-31. doi: 10.1001/archinte.164.17.1925. Arch Intern Med. 2004. PMID: 15451769

8

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A; INITIATE Study Group. Raskin P, et al. Diabetes Care. 2005 Feb;28(2):260-5. doi: 10.2337/diacare.28.2.260. Diabetes Care. 2005. PMID: 15677776 Clinical Trial.

9

The effect of rosiglitazone on overweight subjects with type 1 diabetes.

Strowig SM, Raskin P. Strowig SM, et al. Among authors: raskin p. Diabetes Care. 2005 Jul;28(7):1562-7. doi: 10.2337/diacare.28.7.1562. Diabetes Care. 2005. PMID: 15983301 Clinical Trial.

10

Thiazolidinediones and insulin: rationale for use and role of combination therapy in type 2 diabetes mellitus.

Huang A, Raskin P. Huang A, et al. Among authors: raskin p. Treat Endocrinol. 2005;4(4):205-20. doi: 10.2165/00024677-200504040-00002. Treat Endocrinol. 2005. PMID: 16053338 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters